Ariez B.V.
Podcasts for the professional healthcare people
Ariez B.V.
Prof. Michael Hofman
•
Ariez Publishing
Professor Michael Hofman discusses the phase II results of the TheraP trial and what these results mean for patient's with castration-resistant prostate cancer.